IMNM Operating Cash Flow (Statement)
Immunome Inc · Operating Cash Flow (Statement)
IMNM Operating Cash Flow (Statement)
Latest reported-$208.79Mperiod ending
IMNM TTM Cash from Operations (-$9.60M → -$208.79M)
TTM operating cash flow (statement)
High-resolution chart · PNG
IMNM operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -208,793,000 | |
| -196,502,000 | |
| -190,919,000 | |
| -185,026,000 | |
| -178,683,000 | |
| -152,679,000 | |
| -110,794,000 | |
| -86,193,000 | |
| -60,640,000 | |
| -42,911,000 | |
| -7,568,000 | |
| 3,208,000 | |
| 4,251,000 | |
| 1,859,000 | |
| -28,690,000 | |
| -28,812,000 | |
| -25,386,000 | |
| -21,067,000 | |
| -18,226,000 | |
| -17,483,000 | |
| -15,866,000 | |
| -13,605,000 | |
| -12,134,000 | |
| -8,651,000 | |
| -8,482,000 | |
| -9,333,000 | |
| -9,600,000 |